Patents by Inventor Richard A. Burt

Richard A. Burt has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10828984
    Abstract: Some embodiments of the present invention provide a control system configured to control a driveline of a motor vehicle to operate in a selected one of a plurality of configurations, the system being configured to receive a signal indicative of a location of the vehicle, the system being configured to cause the driveline to operate in a configuration selected in dependence at least in part on the signal indicative of the location of the vehicle.
    Type: Grant
    Filed: October 30, 2018
    Date of Patent: November 10, 2020
    Assignee: JAGUAR LAND ROVER LIMITED
    Inventors: Sam Burt, Christopher Harries, Richard Clarke
  • Patent number: 9867855
    Abstract: The present invention is directed to the use of mitotically and/or lethally inactivated stem cells for the repair of damaged organs and/or tissues. Stem cells are mitotically and/or lethally inactivated and transplanted into damaged tissue. Any form of ex vivo inactivation of stem cells may be used such that the stem cells cannot undergo mitosis or cell division before in vivo application. Mitotically and/or lethally inactivated stem may be used to ameliorate numerous disease, injury, traumatic, ischemic, aging, and/or degenerative conditions in different types of organs and/or tissues.
    Type: Grant
    Filed: April 27, 2015
    Date of Patent: January 16, 2018
    Inventor: Richard Burt
  • Patent number: 9381151
    Abstract: Compositions and methods are provided herein for regenerating and repairing damaged or aged tissue or organs using nonviable lethally irradiated or lyophilized pluripotent stem cells. In one aspect, the compositions and methods described herein provide anti-aging benefits to the skin by increasing the hydration reducing fine lines, wrinkles, and pores of the skin. Compositions and methods are also provided for promoting wound healing using lyophilized pluripotent stem cell powder. A method is provided for inducing cardiac muscle regeneration in a primate comprising delivering nonviable lethally irradiated pluripotent stem cells to damaged or aged areas of the heart. The compositions and methods include nonviable lethally irradiated or lyophilized pluripotent stem cells. In one aspect, the compositions and methods utilize nonviable pluripotent stem cells in the form of a powder, such as lyophilized stem cells.
    Type: Grant
    Filed: May 16, 2014
    Date of Patent: July 5, 2016
    Inventor: Richard Burt
  • Patent number: 9364425
    Abstract: Compositions and methods are provided herein for regenerating and repairing damaged or aged tissue or organs using nonviable lethally irradiated or lyophilized pluripotent stem cells. In one aspect, the compositions and methods described herein provide anti-aging benefits to the skin by increasing the hydration reducing fine lines, wrinkles, and pores of the skin. Compositions and methods are also provided for promoting wound healing using lyophilized pluripotent stem cell powder. A method is provided for inducing cardiac muscle regeneration in a primate comprising delivering nonviable lethally irradiated pluripotent stem cells to damaged or aged areas of the heart. The compositions and methods include nonviable lethally irradiated or lyophilized pluripotent stem cells. In one aspect, the compositions and methods utilize nonviable pluripotent stem cells in the form of a powder, such as lyophilized stem cells.
    Type: Grant
    Filed: March 13, 2013
    Date of Patent: June 14, 2016
    Inventor: Richard Burt
  • Publication number: 20160022744
    Abstract: The present invention is directed to the use of mitotically and/or lethally inactivated stem cells for the repair of damaged organs and/or tissues. Stem cells are mitotically and/or lethally inactivated and transplanted into damaged tissue. Any form of ex vivo inactivation of stem cells may be used such that the stem cells cannot undergo mitosis or cell division before in vivo application. Mitotically and/or lethally inactivated stem may be used to ameliorate numerous disease, injury, traumatic, ischemic, aging, and/or degenerative conditions in different types of organs and/or tissues.
    Type: Application
    Filed: October 5, 2015
    Publication date: January 28, 2016
    Inventor: Richard Burt
  • Publication number: 20150328265
    Abstract: The present invention is directed to the use of mitotically and/or lethally inactivated stem cells for the repair of damaged organs and/or tissues. Stem cells are mitotically and/or lethally inactivated and transplanted into damaged tissue. Any form of ex vivo inactivation of stem cells may be used such that the stem cells cannot undergo mitosis or cell division before in vivo application. Mitotically and/or lethally inactivated stem may be used to ameliorate numerous disease, injury, traumatic, ischemic, aging, and/or degenerative conditions in different types of organs and/or tissues.
    Type: Application
    Filed: April 27, 2015
    Publication date: November 19, 2015
    Inventor: Richard Burt
  • Patent number: 9017658
    Abstract: The present invention is directed to the use of mitotically and/or lethally inactivated stem cells for the repair of damaged organs and/or tissues. Stem cells are mitotically and/or lethally inactivated and transplanted into damaged tissue. Any form of ex vivo inactivation of stem cells may be used such that the stem cells cannot undergo mitosis or cell division before in vivo application. Mitotically and/or lethally inactivated stem may be used to ameliorate numerous disease, injury, traumatic, ischemic, aging, and/or degenerative conditions in different types of organs and/or tissues.
    Type: Grant
    Filed: January 15, 2009
    Date of Patent: April 28, 2015
    Inventor: Richard Burt
  • Publication number: 20140255357
    Abstract: Compositions and methods are provided herein for regenerating and repairing damaged or aged tissue or organs using nonviable lethally irradiated or lyophilized pluripotent stem cells. In one aspect, the compositions and methods described herein provide anti-aging benefits to the skin by increasing the hydration reducing fine lines, wrinkles, and pores of the skin. Compositions and methods are also provided for promoting wound healing using lyophilized pluripotent stem cell powder. A method is provided for inducing cardiac muscle regeneration in a primate comprising delivering nonviable lethally irradiated pluripotent stem cells to damaged or aged areas of the heart. The compositions and methods include nonviable lethally irradiated or lyophilized pluripotent stem cells. In one aspect, the compositions and methods utilize nonviable pluripotent stem cells in the form of a powder, such as lyophilized stem cells.
    Type: Application
    Filed: May 16, 2014
    Publication date: September 11, 2014
    Inventor: Richard Burt
  • Patent number: 8621856
    Abstract: A hydraulic drive train with energy dissipation for electrical generation. A hydraulic pump is provided in the nacelle of the windmill and powered by the wind turbine shaft. This hydraulic pump provides high pressure oil to generators, typically at ground level. The generators are protected from high pressure oil spikes by a pressure relief valve. Electric pumps on the ground level provide or supercharge the oil to the hydraulic pump in the nacelle.
    Type: Grant
    Filed: January 5, 2010
    Date of Patent: January 7, 2014
    Assignee: Windera Power Systems, Inc.
    Inventor: Richard Burt
  • Publication number: 20130243739
    Abstract: Compositions and methods are provided herein for regenerating and repairing damaged or aged tissue or organs using nonviable lethally irradiated or lyophilized pluripotent stem cells. In one aspect, the compositions and methods described herein provide anti-aging benefits to the skin by increasing the hydration reducing fine lines, wrinkles, and pores of the skin. Compositions and methods are also provided for promoting wound healing using lyophilized pluripotent stem cell powder. A method is provided for inducing cardiac muscle regeneration in a primate comprising delivering nonviable lethally irradiated pluripotent stem cells to damaged or aged areas of the heart. The compositions and methods include nonviable lethally irradiated or lyophilized pluripotent stem cells. In one aspect, the compositions and methods utilize nonviable pluripotent stem cells in the form of a powder, such as lyophilized stem cells.
    Type: Application
    Filed: March 13, 2013
    Publication date: September 19, 2013
    Inventor: Richard Burt
  • Publication number: 20100207398
    Abstract: The disclosure relates to a hydraulic drive train with energy dissipation for electrical generation. The disclosure is particularly adapted to wind-driven embodiments wherein the input power can fluctuate quickly. A hydraulic pump is provided in the nacelle of the windmill and powered by the wind turbine shaft. This hydraulic pump provides high pressure oil to generators, typically at ground level. The generators are protected from high pressure oil spikes by a pressure relief valve. Electric pumps on the ground level provide or supercharge the oil to the hydraulic pump in the nacelle.
    Type: Application
    Filed: January 5, 2010
    Publication date: August 19, 2010
    Applicant: WINDERA POWER SYSTEMS INC.
    Inventor: Richard Burt
  • Patent number: 7649274
    Abstract: The disclosure relates to a turbine wherein the rotor windings receive current from a CPU-controlled high speed operational amplifier and the stator windings include four-stage poles with configurations controlled by the CPU. The control of the current to the rotor and the control of the configuration of the four-stage poles of the stator windings is used to provide for constant amplitude (i.e., voltage) and frequency output of the turbine over a range of rotational velocities and loads. The turbine can be used in many applications including, but not limited to, wind or water driven applications.
    Type: Grant
    Filed: February 9, 2007
    Date of Patent: January 19, 2010
    Assignee: Windera Power Systems, Inc.
    Inventor: Richard Burt
  • Publication number: 20090214491
    Abstract: The present invention is directed to the use of mitotically and/or lethally inactivated stem cells for the repair of damaged organs and/or tissues. Stem cells are mitotically and/or lethally inactivated and transplanted into damaged tissue. Any form of ex vivo inactivation of stem cells may be used such that the stem cells cannot undergo mitosis or cell division before in vivo application. Mitotically and/or lethally inactivated stem may be used to ameliorate numerous disease, injury, traumatic, ischemic, aging, and/or degenerative conditions in different types of organs and/or tissues.
    Type: Application
    Filed: January 15, 2009
    Publication date: August 27, 2009
    Inventor: Richard Burt
  • Publication number: 20070182273
    Abstract: The disclosure relates to a turbine wherein the rotor windings receive current from a CPU-controlled high speed operational amplifier and the stator windings include four-stage poles with configurations controlled by the CPU. The control of the current to the rotor and the control of the configuration of the four-stage poles of the stator windings is used to provide for constant amplitude (i.e., voltage) and frequency output of the turbine over a range of rotational velocities and loads. The turbine can be used in many applications including, but not limited to, wind or water driven applications.
    Type: Application
    Filed: February 9, 2007
    Publication date: August 9, 2007
    Inventor: Richard Burt
  • Publication number: 20050221482
    Abstract: The present invention provides an isolated population of adult hematopoietic stem cells (HSC) derived from embryonic stem cells (ESC) induced to differentiate in vitro by culturing ESCs in a medium with stem cell factor, interleukin (IL)-3, and IL-6. HSC of immunophenotype c-kit+ or c-kit+/CD45+ from this population are isolated and injected either intra bone marrow or intravenously into myeloablated recipient individuals. This method allows for the establishment of banks of allogeneic ESC-derived adult stem cells for treatments of autoimmune diseases, immune deficiencies and induction of immunotolerance during organ transplantation. These allogeneic ESC-derived adult hematopoietic stem cells (HSC) may be used in reconstituting bone marrow, without the development of teratomas or graft versus host disease, despite crossing histocompatibility barriers. Additionally, allogeneic ESC-derived HSC can be used to prevent the development of autoimmune diseases or organ rejection during transplantation.
    Type: Application
    Filed: March 31, 2005
    Publication date: October 6, 2005
    Inventors: Richard Burt, Larissa Verda, Charles Link
  • Patent number: 6716956
    Abstract: Disclosed is a process for preparing a polymer of the formula wherein x is an integer of 0 or 1, A is one of several specific groups, such as B is one of several specified groups, such as or mixtures thereof, and n is an integer representing the number of repeating monomer units, said process comprising (A) providing a reaction mixture which comprises (i) a solvent, (ii) a compound of the formula (iii) a compound of the formula (iv) a compound of the formula wherein a is an integer of from 1 to 5, R′ is a hydrogen atom, an alkyl group, an aryl group, an arylalkyl group, an alkylaryl group, an alkoxy group, an aryloxy group, an arylalkyloxy group, an alkylaryloxy group, a polyalkyleneoxy group, or a mixture thereof, and (v) a carbonate base; and (B) heating the reaction mixture and removing generated water from the reaction mixture, thereby effecting a polymerization reaction.
    Type: Grant
    Filed: January 9, 2002
    Date of Patent: April 6, 2004
    Assignee: Xerox Corporation
    Inventors: Timothy P. Bender, Christine J. DeVisser, Richard A. Burt, Paul F. Smith, Marko D. Saban
  • Patent number: 6714014
    Abstract: An apparatus for obtaining resistivity images of a borehole includes an array of measure electrodes separated from a pad or the body of the instrument by a focusing electrode. The focusing electrode is maintained at a slightly higher potential than the measure electrodes. The apparatus is primarily intended for use with conducting fluids but may also be used with non-conducting fluids. A modulated electrical current with a carrier frequency of 1 MHz is injected into the formation. When used with a non-conducting fluid, capacitive coupling between the electrode and the conductive formation is provided by the dielectric of fluid. When used with a conducting borehole fluid, an additional capacitor may be incorporated into the circuit. The current in the measure electrode is indicative of the conductivity of the formation.
    Type: Grant
    Filed: April 18, 2001
    Date of Patent: March 30, 2004
    Assignee: Baker Hughes Incorporated
    Inventors: Martin Townley Evans, Andrew Richard Burt, Albert Alexy
  • Patent number: 6645687
    Abstract: A process comprising forming chlorogallium phthalocyanine (ClGaPc) in N-methyl-2-pyrrolidinone (NMP) to provide a ClGaPc (NMP) Type I; separately dry milling and then wet treating the Type I product to form Type II ClGaPc (NMP); blending the ClGaPc Type II product with hydroxygallium phthalocyanine (HOGaPc) Type V and a resin to form a coating mixture; coating the resulting mixture to form a photoconductive charge generator layer.
    Type: Grant
    Filed: May 10, 2002
    Date of Patent: November 11, 2003
    Assignee: Xerox Corporation
    Inventors: Cuong Vong, George Liebermann, Richard A. Burt, Ah-Mee Hor
  • Publication number: 20030176621
    Abstract: Disclosed is a process for preparing a polymer of the formula 1
    Type: Application
    Filed: January 9, 2002
    Publication date: September 18, 2003
    Applicant: Xerox Corporation
    Inventors: Timothy P. Bender, Christine J. DeVisser, Richard A. Burt, Paul F. Smith, Marko D. Saban
  • Publication number: 20030013029
    Abstract: A process including: forming a first chlorogallium phthalocyanine (ClGaPc) in N-methyl-2-pyrrolidone (NMP) to form a ClGaPc (NMP) Type-I product; forming a second chlorogallium phthalocyanine in dimethyl sulfoxide (DMSO) to form a ClGaPc (DMSO) Type-I product; separately dry milling and then wet treating the Type-I products to form respective Type-II products; blending the Type-II products together along with a resin to form a coating mixture; and coating the mixture to form a charge generator layer in an electrostatographic imaging article.
    Type: Application
    Filed: March 23, 2001
    Publication date: January 16, 2003
    Applicant: Xerox Corporation
    Inventors: Richard A. Burt, George Liebermann, Cheng-Kuo Hsiao, Ah-Mee Hor